It’s no easy gig analysing share prices and company performance but somebody’s got to do it. Two experts give us their ...

Strong patient demand and expanding trial sites are helping Paradigm progress its long-awaited phase III knee OA study.

Backed by government and industry partners, Micro-X is pushing its cold-cathode X-ray tech toward commercial readiness.

Rare earths and mineral sands hopeful Ark Mines wants to ride a wave of government support to production as soon as 2027.

Copper comes at a premium, and Garimpeiro likes the upside in one of the largest deposits owned by a junior developer.

Gold prices have hit a wall after a massive run-up, but miners are well placed to make money and experts say fundamentals are ...

Spodumene prices have passed US$1000/t thanks to booming demand from battery energy storage systems, and lithium miners are ...

The Reserve Bank might have posted its last rates cut in the current easing cycle, but the impact on shares might be less ...

Gold miners were hit after the US Government shutdown ended, but plenty of positive news around the sector is pointing to ...

The ASX 200 burned through five months of gains, resetting to levels last seen in July. Energy provided some support as crude ...

The ASX healthcare sector finished the week in a steady state, despite ripple effects of a sharp sell-off on Wall Street.

The US Government push to build US$80bn worth of new nuclear reactors and VanEck’s launch of a uranium ETF are signs that ...